The diagnostic utility of MOC31, BerEP4, RCC marker and CD10 in the classification of renal cell carcinoma and renal oncocytoma: An immunohistochemical analysis of 328 cases

Histopathology

Volumn 45, Issue 5, 2004, Pages 452-459

  Pan, Chin Chen ^a,b   Chen, P C H ^a   Ho, D M T ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

BerEP4; CD10; Immunohistochemistry; MOC31; RCC marker; Renal cell carcinoma; Renal oncocytoma

Indexed keywords

BEREP4 ANTIGEN; CD15 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYTOKERATIN; EPITHELIAL MEMBRANE ANTIGEN; MOC31 ANTIGEN; MONOCLONAL ANTIBODY; RENAL CELL CARCINOMA MARKER; TUMOR MARKER; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN;

ARTICLE; CANCER CLASSIFICATION; CLEAR CELL CARCINOMA; DIAGNOSTIC VALUE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; KIDNEY ONCOCYTOMA; MULTIVARIATE ANALYSIS; ONCOCYTOMA; PAPILLARY CARCINOMA; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ADENOMA, OXYPHILIC; ANTIGENS, NEOPLASM; BIOLOGICAL MARKERS; CARCINOMA, RENAL CELL; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; MITOGEN-ACTIVATED PROTEIN KINASES; NEPRILYSIN; TUMOR MARKERS, BIOLOGICAL;

EID: 8744275610     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2004.01962.x     Document Type: Article

References (23)

1. Eble JN, Sauter G, Epstein JI, Sesterhenn IA. World Health Organization classification of tumours. Pathology and genetics of tumours of the urinary system and male genital organs. Lyon: IARC Press, 2004.
2. Kovacs G, Akhtar M, Beckwith BJ et al. The Heidelberg classification of renal cell tumours. J. Pathol. 1997; 183; 131-133.
3. Amin MB, Amin MB, Tamboli P et al. Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: an experience of 405 cases. Am. J. Surg. Pathol. 2002; 26; 281-291.
4. Renshaw AA. Subclassification of renal cell neoplasms: an update for the practising pathologist. Histopathology 2002; 41; 283-300.
5. Cheville JC, Lohse CM, Zincke H, Weaver AL, Blute ML. Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am. J. Surg. Pathol. 2003; 27; 612-624.
6. Cochand-Priollet B, Molinie V, Bougaran J et al. Renal chromophobe cell carcinoma and oncocytoma. A comparative morphologic, histochemical, and immunohistochemical study of 124 cases. Arch. Pathol. Lab. Med. 1997; 121; 1081-1086.
7. Kim MK, Kim S. Immunohistochemical profile of common epithelial neoplasms arising in the kidney. Appl. Immunohistochem. Mol. Morph. 2002; 10; 332-338.
8. Tickoo SK, Amin MB, Linden MD, Lee MW, Zarbo RJ. Antimitochondrial antibody (113-1) in the differential diagnosis of granular renal cell tumors. Am. J. Surg. Pathol. 1997; 21; 922-930.
9. Tickoo SK, Amin MB, Zarbo RJ. Colloidal iron staining in renal epithelial neoplasms, including chromophobe renal cell carcinoma: emphasis on technique and patterns of staining. Am. J. Surg. Pathol. 1998; 22; 419-424.
10. Wu SL, Kothari P, Wheeler TM, Reese T, Connelly JH. Cytokeratins 7 and 20 immunoreactivity in chromophobe renal cell carcinomas and renal oncocytomas. Mod. Pathol. 2002; 15; 712-717.
11. Avery AK, Beckstead J, Renshaw AA, Corless CL. Use of antibodies to RCC and CD10 in the differential diagnosis of renal neoplasms. Am. J. Surg. Pathol. 2000; 24; 203-210.
12. McGregor DK, Khurana KK, Cao C et al. Diagnosing primary and metastatic renal cell carcinoma: the use of the monoclonal antibody 'Renal Cell Carcinoma Marker'. Am. J. Surg. Pathol. 2001; 25; 1485-1492.
13. Bubendorf L, Nocito A, Moch H, Sauter G. Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughput in situ studies. J. Pathol. 2001: 195; 72-79.
14. Tickoo SK, Lee MW, Eble JN et al. Ultrastructural observations on mitochondria and microvesicles in renal oncocytoma, chromophobe renal cell carcinoma, and eosinophilic variant of conventional (clear cell) renal cell carcinoma. Am. J. Surg. Pathol. 2000; 24; 1247-1256.
15. Krishnan B, Truong ID. Renal epithelial neoplasms: the diagnostic implications of electron microscopic study in 55 cases. Hum. Pathol. 2002; 33; 68-79.
16. Latham B, Dickersin GR, Oliva E. Subtypes of chromophobe cell renal carcinoma: an ultrastructural and histochemical study of 13 cases. Am. J. Surg. Pathol. 1999; 23; 530-535,
17. Taki A, Nakatani Y, Misugi K, Yao M, Nagashima Y. Chromophobe renal cell carcinoma: an immunohistochemical study of 21 Japanese cases. Mod. Pathol. 1999; 12; 310-317.
18. Attanoos RL, Goddard H, Thomas ND, Jasani B, Gibbs AR. A comparative immunohistochemical study of malignant mesothelioma and renal cell carcinoma: the diagnostic utility of Leu-M1, Ber EP4, Tamm-Horsfall protein and thrombomodulin. Histopathology 1995; 27; 361-366.
19. Leroy X, Moukassa D, Copin MC, Saint F, Mazeman E, Gosselin B. Utility of cytokeratin 7 for distinguishing chromophobe renal cell carcinoma from renal oncocytoma. Eur. Urol. 2000; 37; 484-487.
20. Satoh F, Tsutsumi Y, Yokoyama S, Osamura RY. Comparative immunohistochemical analysis of developing kidneys, nephroblastomas and related tumors: considerations on their histogenesis. Pathol. Int. 2000; 50; 458-471.
21. Davila RM, Kissane JM, Crouch EC. Multilocular renal cyst. Immunohistochemical and lectin-binding study. Am. J. Surg. Pathol. 1992; 16; 508-514.
22. Holm-Nielsen P, Pallesen G. Expression of segment-specific antigens in the human nephron and in renal epithelial tumors. APMIS Suppl. 1988; 4; 48-55.
23. Yoshida SO, Imam A. Monoclonal antibody to a proximal nephrogenic renal antigen: immunohistochemical analysis of formalin-fixed, paraffin-embedded human renal cell carcinomas. Cancer Res. 1989; 49; 1802-1809.